Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Times Interest Earned: 2016-2025

Historic Times Interest Earned for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $2.85.

  • Collegium Pharmaceutical's Times Interest Earned rose 50.60% to $2.85 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.83, marking a year-over-year decrease of 33.13%. This contributed to the annual value of $2.30 for FY2024, which is 14.64% up from last year.
  • Collegium Pharmaceutical's Times Interest Earned amounted to $2.85 in Q3 2025, which was up 66.27% from $1.72 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Times Interest Earned registered a high of $3.70 during Q1 2021, and its lowest value of -$7.17 during Q4 2021.
  • Its 3-year average for Times Interest Earned is $2.11, with a median of $1.89 in 2024.
  • Its Times Interest Earned has fluctuated over the past 5 years, first plummeted by 470.08% in 2021, then soared by 459.91% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Times Interest Earned (Quarterly) stood at -$7.17 in 2021, then surged by 107.97% to $0.57 in 2022, then surged by 459.91% to $3.20 in 2023, then slumped by 47.42% to $1.68 in 2024, then soared by 50.60% to $2.85 in 2025.
  • Its Times Interest Earned stands at $2.85 for Q3 2025, versus $1.72 for Q2 2025 and $1.04 for Q1 2025.